Related references
Note: Only part of the references are listed.PNU282987 inhibits amyloid-β aggregation by upregulating astrocytic endogenous αB-crystallin and HSP-70 via regulation of the α7AChR, PI3K/Akt/HSF-1 signaling axis
Zhenkui Ren et al.
MOLECULAR MEDICINE REPORTS (2020)
Pimavanserin exhibits serotonin 5-HT2A receptor inverse agonism for Gαi1- and neutral antagonism for Gαq/11-proteins in human brain cortex
Itziar Muneta-Arrate et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Impact of SSRI Therapy on Risk of Conversion From Mild Cognitive Impairment to Alzheimer's Dementia in Individuals With Previous Depression
Claudia Bartels et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms
Matthias Brendel et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway
Ines Ibarra-Lecue et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD
Antonella Tramutola et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Glutamate receptors function as scaffolds for the regulation of β-amyloid and cellular prion protein signaling complexes
Alison Hamilton et al.
MOLECULAR BRAIN (2015)
An Antidepressant Decreases CSF Aβ Production in Healthy Individuals and in Transgenic AD Mice
Yvette I. Sheline et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Serotonin signaling is associated with lower amyloid-β levels and plaques in transgenic mice and humans
John R. Cirrito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Share Paper
